CCI clears Abbott-St Jude deal subject to 'voluntary remedies'
Abbott Competition Commission of India Abbott Laboratories GlaxoSmithKline
In a tweet, Competition Commission of India (CCI) said it has approved the "proposed combination between St Jude Medical and Abbott Laboratories; subject to voluntary remedies".
https://economictimes.indiatimes.com/icons/etfavicon.ico
The Economic Times
(Catch all the Business News, Breaking News, Budget 2024 Events and Latest News Updates on The Economic Times.)

Subscribe to The Economic Times Prime and read the ET ePaper online.